Trials / Completed
CompletedNCT00142207
Preventing Malaria During Pregnancy in Epidemic-prone Areas.
The Efficacy and Cost-effectiveness of Malaria Prevention in Pregnancy in an Area of Low and Unstable Transmission in Kabale, Uganda: Use of Intermittent Preventive Treatment and Insecticide-treated Nets.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 4,775 (actual)
- Sponsor
- London School of Hygiene and Tropical Medicine · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the efficacy and cost-effectiveness of three alternative strategies for the prevention of malaria during pregnancy in an epidemic-prone area of low transmission in the East African Highlands. The strategies being compared are: * intermittent preventive treatment with sulfadoxine-pyrimethamine (IPT-SP) * an insecticide treated net (ITN), and * intermittent preventive treatment with SP plus an ITN In addition to the main individually-randomised trial, outcome data was subsequently also gathered on pregnant women whose houses where sprayed with indoor residual insecticides (IRS) as part of a non-randomised district-wide control programme to compare the impact of IRS with the three intervention arms.
Detailed description
Susceptibility to malaria infection during pregnancy and the severity of clinical manifestation are determined by the level of pre-pregnancy immunity, which depends on intensity and stability of malaria transmission. Most intervention trials to prevent malaria during pregnancy have been conducted in areas of intense transmission. The results of trials conducted in high-transmission areas may not be applicable to low transmission areas, where malaria is less frequent but the risk of spontaneous abortion and stillbirth is very high in women of all parities due to lack of sufficient malaria immunity. Routine chemoprophylaxis is generally not recommended in areas of unstable malaria transmission. However, intermittent treatment with an effective anti-malarial drug may be beneficial, especially during periods of malaria transmission. Little work has been carried out amongst pregnant women living in areas of low and unstable transmission in Africa. No data are available on the cost-effectiveness of malaria control in low transmission settings. This study will compare the efficacy and cost effectiveness of three preventive strategies for the control of malaria during pregnancy in low-transmission settings. The study is located in Kabale district, a highland area in SW Uganda. Women attending antenatal care are randomised to receive either: * intermittent preventive treatment with sulfadoxine-pyrimethamine (IPT-SP) * an insecticide treated net (ITN), or * intermittent preventive treatment with SP and an ITN. It is hypothesized that when combined with IPT-SP, the additional impact of ITNs by reducing exposure may be greatest where the intensity of transmission is low. In addition to the main individually-randomised trial, outcome data was subsequently also gathered on pregnant women whose houses where sprayed with indoor residual insecticides (IRS) as part of a non-randomised district-wide control programme to compare the impact of IRS with the three intervention arms. The study aims to identify the most effective intervention strategies suited to areas characterised by low and unstable transmission. Research findings should be applicable to other hypoendemic areas of the East African highlands.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Intermittent preventive treatment:sulphadoxine-pyrimethamine | Two doses given twice during pregnancy (once in the second trimester, and once in the third trimester). Oral medication in tablet form: single daily dose given on each occasion |
| DEVICE | Insecticide-treated mosquito bed net | Insecticide-treated mosquito bed net |
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2007-01-01
- Completion
- 2007-01-01
- First posted
- 2005-09-02
- Last updated
- 2017-01-12
Locations
1 site across 1 country: Uganda
Source: ClinicalTrials.gov record NCT00142207. Inclusion in this directory is not an endorsement.